SI-BONE, Inc. (SIBN) News
Follow SI-BONE, Inc. (SIBN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 23 public stories across 10 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
SI-BONE Posts 14.5% Revenue Growth as Procedure Volume Rises 19.5%
EQUITY | Nov 04, 2026, 08:01 AM UTC
M
SI-BONE Reports Third-Quarter Revenue of $55.7 Million
Third-quarter 2026 revenue rose 14.5% from a year earlier. Net loss narrowed to $3.62 million from $4.57 million, and diluted loss per share improved to $0.08 from $0.11.
EQUITY | Nov 03, 2026, 09:13 PM UTC
M
SI-BONE Revenue Rises 14.5%; iFuse Wins FDA Clearance
EQUITY | Nov 03, 2026, 08:03 AM UTC
M
SI-BONE Reports Third-Quarter Revenue of $55.7 Million, Cuts Expense Growth Outlook
SI-BONE reported third-quarter 2026 revenue of $55.7 million, net loss of $3.6 million, or $0.08 per diluted share, and adjusted EBITDA of $3.0 million. It reaffirmed 2026 worldwide revenue and gross margin guidance whil
EQUITY | Nov 02, 2026, 10:33 PM UTC
M
SI-BONE Reports Third-Quarter Loss of $3.62 Million
EQUITY | Nov 02, 2026, 09:25 PM UTC
M
SI-BONE Reports Third-Quarter Revenue of $55.7M
EQUITY | Nov 02, 2026, 09:25 PM UTC
M
SI-BONE Q3 Revenue Rises 14.5%, Slightly Beats Estimates
EQUITY | Nov 02, 2026, 09:22 PM UTC
M
SI-BONE reports Q3 operating loss
EQUITY | Nov 02, 2026, 09:16 PM UTC
M
SI-BONE Reports Q3 Gross Margin of 79.3%
EARNINGS | Nov 02, 2026, 09:13 PM UTC
M
SI-BONE Reports Q3 Basic EPS of USD -0.08
EARNINGS | Nov 02, 2026, 09:13 PM UTC
M
SI-BONE Reports Q3 Net Income of USD -3.62 Million
EARNINGS | Nov 02, 2026, 09:13 PM UTC
M
SI-BONE Q3 Revenue Reaches $55.704 Million
Revenue was USD 55.704 million versus an IBES estimate of USD 55.4 million. Reuters also reported net income of USD -3.62 million.
EQUITY | Nov 02, 2026, 09:10 PM UTC
M
SI-BONE Sets Q3 2026 Results Release for Nov. 2
SI-BONE will report third-quarter 2026 financial results after market close on Nov. 2, 2026. A conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET.
EQUITY | Oct 19, 2026, 08:14 PM UTC
L
SI-BONE, Inc. (SIBN) Wins FDA 510(k) for iFuse Granite Onyx
SI-BONE received FDA 510(k) clearance for the iFuse Granite Onyx system, its first compromised-bone product for use outside the pelvis, targeting screw loosening at spinal fusion UIV/LIV.Material DetailsContext by AI Ana
REGULATION | Sep 28, 2026, 08:11 PM UTC
L
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density boneSANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. NASDAQ:SIBN, the global leader in developing proc
REGULATION | Sep 28, 2026, 08:11 PM UTC
M
SI-BONE gets FDA 510(k) clearance for iFuse Granite Onyx
SI-BONE said the FDA cleared iFuse Granite Onyx under 510(k).
REGULATION | Sep 28, 2026, 08:09 PM UTC
M
Russian seaborne oil product exports rise 16.4% in August
Russia’s seaborne oil product exports rose 16.4% month-on-month in August to 4.57 million metric tons, according to industry sources and Reuters calculations.
ENERGY | Sep 17, 2026, 02:01 PM UTC
L
SI-BONE Enters Fourth Amendment To Lease On Sept 11, 2026 - SEC Filing
SI-BONE, Inc. NASDAQ:SIBN
REGULATION | Sep 11, 2026, 08:27 PM UTC
L
SI-BONE to present at Morgan Stanley Global Healthcare Conference Sep 14, 2026
SI-BONE (SIBN) said it will present at the Morgan Stanley 24th Global Healthcare Conference on September 14, 2026.
EQUITY | Aug 31, 2026, 08:09 PM UTC
L
SI-BONE Raises FY2026 Sales Guidance from $230.000M-$233.000M to $231.000M-$233.000M vs $231.775M Est
SI-BONE (NASDAQ: SIBN ) raises FY2026 sales outlook from $230.000 million-$233.000 million to $231.000 million-$233.000 million vs $231.775 million estimate.
EARNINGS | Aug 03, 2026, 08:25 PM UTC
L
SIBN - SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
SIBN - SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
EARNINGS | Aug 03, 2026, 08:09 PM UTC
L
SIBN Initiated Buy W/$24.00 PT at UBS
SIBN Initiated Buy W/$24.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: O
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: OUTPERFORM @ Wedbush CRWD: BUY @ Loop FTH: OUTPERFORM @ Opp HRB: EQUAL WEIGHT @ S
EQUITY | Jul 28, 2026, 11:11 AM UTC